Generation dependent hemolytic profile of folate engineered poly(propyleneimine) dendrimer

Journal of Drug Delivery Science and Technology

Volumn 28, Issue , 2015, Pages 1-6

  Kesharwani, Prashant ^a   Mishra, Vijay ^a   Jain, Narendra Kumar ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

Erythrocytes; Hemolytic toxicity; PPI dendrimer; Surface engineering

Indexed keywords

FOLIC ACID; HEMOGLOBIN; NANOCARRIER; POLY(PROPYLENEIMINE) DENDRIMER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD TOXICITY; CELL STRUCTURE; CONJUGATION; DRUG DELIVERY SYSTEM; ERYTHROCYTE; HEMATOLOGICAL PARAMETERS; HEMOLYSIS; HUMAN; HUMAN CELL; PHARMACEUTICAL ENGINEERING; SYNTHESIS;

EID: 84937957626     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jddst.2015.04.006     Document Type: Article

References (26)

1. B. Birdhariya, P. Kesharwani, N.K. Jain, Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers, Drug Dev. Ind. Pharm. (2014) 1-7, http://dx.doi.org/10.3109/03639045.2014.954584.
2. P. Kesharwani, V. Gajbhiye, N.K. Jain, A review of nanocarriers for the delivery of small interfering RNA, Biomaterials 33 (2012) 7138-7150.
3. P. Kesharwani, R.K. Tekade, N.K. Jain, Dendrimer generational nomenclature: the need to harmonize, Drug Discov. Today (2015), http://dx.doi.org/10.1016/j.drudis.2014.12.015.
4. P. Kesharwani, K. Jain, N.K. Jain, Dendrimer as nanocarrier for drug delivery, Prog. Polym. Sci. 39 (2014) 268-307.
5. V. Mishra, N.K. Jain, Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits, Int. J. Pharm. 461 (2014) 380-390.
6. K. Jain, P. Kesharwani, U. Gupta, N.K. Jain, A review of glycosylated carriers for drug delivery, Biomaterials 33 (2012) 4166-4186.
7. S. Thakur, R.K. Tekade, P. Kesharwani, N.K. Jain, The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers, J. Nanoparticle Res. 15 (2013) 1625, http://dx.doi.org/10.1007/s11051-013-1625-2.
8. P. Kesharwani, V. Gajbhiye, R.K. Tekade, N.K. Jain, Evaluation of dendrimer safety and efficacy through cell line studies, Curr. Drug Targets 12 (2011) 1478-1497.
9. V. Mishra, P. Kesharwani, N.K. Jain, siRNA nanotherapeutics: a trojan horse approach against HIV, Drug Discov. Today 19 (2014) 1913-1920.
10. K. Jain, P. Kesharwani, U. Gupta, N.K. Jain, Dendrimer toxicity: let's meet the challenge, Int. J. Pharm. 394 (2010) 122-142.
11. P. Kesharwani, A.K. Iyer, Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery, Drug Discov. Today (2014), http://dx.doi.org/10.1016/j.drudis.2014.12.012.
12. P. Kesharwani, R. Ghanghoria, N.K. Jain, Carbon nanotube exploration in cancer cell lines, Drug Discov. Today 17 (2012) 1023-1030.
13. V. Mishra, U. Gupta, N.K. Jain, Surface-engineered dendrimers: a solution for toxicity issues, J. Biomater. Sci. Polym. 20 (2009) 141-166.
14. S. Thakur, P. Kesharwani, R.K. Tekade, N.K. Jain, Impact of pegylation on biopharmaceutical properties of dendrimers, Polym. Guildf. 59 (2015) 67-92.
15. P. Kesarwani, R.K. Tekade, N.K. Jain, Spectrophotometric estimation of paclitaxel, Int. J. Adv. Pharm. Sci. 2 (2011) 29-32.
16. P. Kesharwani, R.K. Tekade, V. Gajbhiye, K. Jain, N.K. Jain, Cancer targeting potential of some ligand-anchored poly(propylene imine) dendrimers: a comparison, nanomedicine nanotechnology, Biol. Med. 7 (2011) 295-304.
17. U. Gupta, S.K.D. Dwivedi, H.K. Bid, R. Konwar, N.K. Jain, Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells, Int. J. Pharm. 393 (2010) 185-196.
18. P. Kesharwani, R.K. Tekade, N.K. Jain, Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector, Nanomedicine (Lond) 9(15) (2014) 2291-2308. http://www.ncbi.nlm.nih.gov/pubmed/24593000.
19. S. Jain, P. Kesharwani, R.K. Tekade, N.K. Jain, One platform comparison of solubilization potential of dendrimer with some solubilizing agents, Drug Dev. Ind. Pharm. (2014), http://dx.doi.org/10.3109/03639045.2014.900077.
20. V. Mishra, U. Gupta, N.K. Jain, Influence of different generations of poly(-propylene imine) dendrimers on human erythrocytes, Pharmazie 65 (2010) 891-895.
21. P. Kesharwani, R.K. Tekade, N.K. Jain, Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer, Biomaterials 35 (2014) 5539-5548.
22. N.K. Jain, M.S. Tare, V. Mishra, P.K. Tripathi, The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-anti-body conjugates containing encapsulated paclitaxel, Nanomedicine 11 (2015) 207-218.
23. D.M. Domanski, B. Klajnert, M. Bryszewska, Influence of PAMAM dendrimers on human red blood cells, Bioelectrochemistry 63 (2004) 189-191.
24. B. Ziemba, A. Janaszewska, K. Ciepluch, M. Krotewicz, W.A. Fogel, D. Appelhans, et al, In vivo toxicity of poly(propyleneimine) dendrimers, J. Biomed. Mater. Res. A 99 (2011) 261-268.
25. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J.W. Weener, et al, Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamido-amine dendrimers in vivo, J. Control. Release 65 (2000) 133-148.
26. H.B. Agashe, T. Dutta, M. Garg, N.K. Jain, Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer, J. Pharm. Pharmacol. 58 (2006) 1491-1498.